Estradiol physiologically increases in response to increased testosterone, and therefore, both levels are higher; however, a rise in estradiol may be a pathological increase due to an exacerbation of aromatase activity, which is present in metabolic and inflammatory dysfunctions, such as obesity and diabetes. This evidence concerns the gene CYP19A1 and obesity disorder.